Overview

Study of Apatinib and Capecitabine Combination to Maintain Treating Metastatic Colorectal Cancer

Status:
Unknown status
Trial end date:
2018-04-30
Target enrollment:
Participant gender:
Summary
To control apatinib and capecitabine combination to maintain treating metastatic colorectal cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Yanqiao Zhang
Treatments:
Apatinib
Benzocaine
Capecitabine